Blueberries Medical Corp.
BBM
CNSX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -73.83% | 352.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -73.83% | 352.90% | |||
| Cost of Revenue | -80.41% | 694.94% | |||
| Gross Profit | -66.24% | 204.47% | |||
| SG&A Expenses | -32.84% | 34.02% | |||
| Depreciation & Amortization | -94.15% | -2.84% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -47.56% | 60.87% | |||
| Operating Income | 27.97% | -8.56% | |||
| Income Before Tax | 66.12% | -160.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 66.12% | -160.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 66.12% | -160.31% | |||
| EBIT | 27.97% | -8.56% | |||
| EBITDA | 19.84% | -10.05% | |||
| EPS Basic | 71.43% | -133.33% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 71.43% | -133.33% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | -8.39% | 9.15% | |||
| Average Diluted Shares Outstanding | -8.39% | 9.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||